A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...

Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...

AS Heart Month reminds us of the critical need to protect our cardiovascular and metabolic health, Novo Nordisk Philippines and the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM) ...

The drugmaker Novo Nordisk can meet current and future demand in the U.S., the Food and Drug Administration said. But patients may still see some supply disruptions as the medications move from ...

Starting from Monday, February 24th, in the Municipality of Bacoli, activities will commence for the analysis of building facades, as part of the implementation of the extraordinary plan for ...

Infinity Constructions worked in partnership with Robertson Facade Systems ... This 26-storey, 533-bed building sits at the gateway to Melbourne’s university precinct, in close proximity ...

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.51%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...

European stocks rose for a ninth straight week, boosted by shares of chemicals companies and Novo Nordisk A/S gains. Traders are also looking ahead to German elections on Sunday. The Stoxx Europe ...

Novo Nordisk (NYSE: NVO) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly) that's also probably bad news for Hims & Hers Health (NYSE: HIMS).